Best Startup
At Best Startup US we track over 1,000,000 US startups and over 3 million people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United States based Director operating in the Medical Device space. If you think a Director is missing from this list, feel free to contact our editor on editor@beststartup.us.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Eric Moskow
Chief Executive Officer, Director of Accuity Delivery Systems
Founder, CEO and Executive of several highly successful healthcare ventures; including DDDS, OBDS, and Cybear. Dr. Moskow is recognized as an innovative leader in the efficient operation of medical practices. He formed Outcome Based Delivery Systems, with operations in South Florida, Orlando, Florida and Las Vegas, Nevada, which OBDS sold in October 2011. From its founding in 2006 through the sale of its operations, OBDS built its revenue base from a run rate of $0 in 2006 to more than $80M in 2011. He formed Coral Gate Medical Group, a medical practice in Broward County, Florida, in January 2002 and has operated as its Managing Partner since inception. From 2002 to 2005, Coral Gate’s revenues increased from $350,000 to $3.5 million. From February 2000 through January 2002, Dr. Moskow served as Executive Vice President of Cybear, an information technology company serving the health care industry formed by Andrx Corp. He served as a Director of Cybear from June 1999 to 2002. From September 1996 to January 2000, Dr. Moskow was Executive Vice President of Strategic Planning for Phymatrix, a publicly-traded multi-specialty medical provider network. In addition, during this period and then through March 2002, he served as a Director of Phymatrix and its successor, Innovative Clinical Solutions, Ltd. (“ICSL”). From 1989 to 1997, Dr. Moskow served as an Internist and President of Family Medical Associates in Ridgefield, Connecticut. During part of this same period, from October 1995 to October 1996, Dr. Moskow served as Executive Vice President of Physician’s Choice Management, LLC (“PCM”), which he co-founded. In addition, from 1988 to 1992, Dr. Moskow served as Associate Medical Director in Connecticut for U.S. Healthcare. Dr. Moskow is board certified in internal medicine. He received his B.S. degree from Vassar College in 1980 and his M.D. degree from New York Medical College in 1984.
Follow Eric Moskow:
About Accuity Delivery Systems: Accuity Delivery Systems is a provider of clinical documentation services for the healthcare industry.
Marie Auguste
Director of Materials Planning of Drive Medical
Marie Auguste joined Drive Medical in 2006 as Purchasing Manager. With over 20 years of experience in international business, Marie holds a Suny Maritime MBA in International Business and Trade. As a result of her leadership and dedication during the SAP implementation she was named Director or Materials Planning in 2009. Her primary responsibilities are not limited to but include data integrity, forecast and developing demand planning work processes in conjunction with Management & Commodity teams. Prior to joining Drive Marie held positions as a Production Manger for woven products at GAP International, and Purchasing Manager for Professional Audio products at Samson Technologies.
Follow Marie Auguste:
About Drive Medical, Premier: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Scott Marshall
Managing Director of Precision Analytics of Precision for Medicine
Scott Marshall is the Managing Director, Provide Technology Driven Biomarker Data Integration & Computational Biology at QuartzBio.
Follow Scott Marshall:
About Precision for Medicine, Quartz Bio: Precision for Medicine is a specialized scientific services company helping life science innovators develop medical products.
Maren Ohaks Katzaroff
Director – Strategic Planning of Vivos Inc
Maren drives the commercialization of AMI’s brachytherapy products including operational and regulatory aspects through strategic initiatives. Maren has extensive expertise in global commercialization strategies, operations, strategic planning and regulatory compliance in a variety of sectors including medical device, biotechnology, academia and banking. Maren has been instrumental in preparing device and drug products for FDA review including quality system establishment, manufacturing oversight, preparation of FDA filings and participation in FDA reviews. Prior to joining AMI, Maren was employed by the University of Washington (UW) to create and run programs to facilitate engagement between industry and UW researchers and students to foster commercialization of UW technology. This included opening and running the first UW managed high tech incubator. In addition, Maren has held key strategic and operational roles for a number of medical device and biotechnology companies including Amgen and several Seattle area start-ups. She earned an MBA with an emphasis in Management and Technology, and a BS in Cell and Molecular Biology with a minor in Chemistry, both from the UW. Maren enjoys active roles in numerous community organizations.
Follow Maren Ohaks Katzaroff:
About Vivos Inc: Vivos Inc develops manufacturing equipments for the production of medical isotopes used in diagnosis and treatment of diseases.
Donald A. Ludwig
Director of Special Projects of Vivos Inc
Donald A. Ludwig, PhD., is Director of Special Projects for AMI. As an expert in particle accelerator applications in radiation therapy, nuclear medicine and radioisotope production Dr. Ludwig also serves as an advisor to numerous entities in the field, both domestic and foreign. Among these are the Atomic Energy of Canada, the U. S. Department of Energy Labs at Los Alamos, Berkeley, Fermi, Hanford and Oak Ridge, the Israel Atomic Energy Agency, the Australian Nuclear Science and Technology Organization, the Budker Institute of Nuclear Physics in Novosibirsk, Siberia, the Malaysian Institute of Nuclear Technology and the Bhabha Atomic Research Center in Mumbai, India. He holds advanced degrees in nuclear physics, medical physics and marketing from top tier Universities. Dr. Ludwig’s endeavors for AMIC are focused on facilitating the return of clinical radioisotope production to the US, and aiding AMIC in becoming the largest provider of radioisotopes in North America.
Follow Donald A. Ludwig:
About Vivos Inc: Vivos Inc develops manufacturing equipments for the production of medical isotopes used in diagnosis and treatment of diseases.
Bret Henning
Sr Director and Information Technology of Tandem Diabetes Care
Bret Henning is currently the Sr. Director of Information Technology at Tandem Diabetes Care, Inc. Bret is responsible for worldwide IT operations including infrastructure, cloud computing, collaboration technologies, enterprise applications, DEVOPS, call center and voice technologies. At Tandem Bret was involved in building the company from an early stage startup through product commercialization. He brings a diverse portfolio of experience managing everything from Facilities to Connected Heath. His background includes more than 30 years of hands-on experience in technology for electronics and medical device companies.
Follow Bret Henning:
About Tandem Diabetes Care: Tandem Diabetes Care develops medical devices for the treatment of diabetes offering diabetic insulin pumps for adults and children.
Caleb Winder
Managing Director of Excel Venture Management
Caleb Winder is a venture capitalist who focused on life sciences, healthcare and information technology. He is currently a Managing Director at Excel Venture Management & at the MemorialCare Innovation Fund Caleb has a broad set of experiences from his early career in sales and marketing at small and medium sized companies in the diagnostics and medical capital equipment business and from his work in marketing, business development, and finance at various startups. Caleb currently serves on the boards of ClearDATA, Aileron Therapeutics, InfoBionic, WellDoc, Ayogo Health, and Qstream. He formerly served on the boards at Cleveland Heartlab, MedVentive, Saladax, ShapeUp, Oculus Health, Aventura, and Xcellerex
Follow Caleb Winder:
About AristaMD, Excel Venture Management, Excel Venture Management, Foldax, Laudio, LeanTaaS, MemorialCare Innovation Fund, Olive, Phynd Technologies, Xealth: Excel Venture Management builds companies that apply transformative life science technologies to solve problems in healthcare and beyond.
Juan Enriquez
Managing Director of Excel Venture Management
Juan Enriquez is a Managing Director at Excel Venture Management. He is a leading authority on the economic impact of life sciences on business and society, and a respected business leader and entrepreneur. He represents Excel on the boards of Shape Up the Nation, Fina Technologies, Catch.com, and Synthetic Genomics, as well as Activate Networks. Prior to Excel, Enriquez was the Founding Director of the Harvard Business School’s Life Sciences Project, with many of his innovative thoughts captured in his bestselling book, As the Future Catches You, which provides an accurate blueprint of how a bio-based economy changes industries and corporations. Following HBS, Enriquez became an active angel investor and founder of Biotechonomy Ventures, which invested in BioTrove, Xcellerex, and Synthetic Genomics, a company he co-founded with Drs. J. Craig Venter and Hamilton Smith, to apply life sciences to energy markets. As a business leader, advisor, and renowned speaker, he works directly with the CEOs of a number of Fortune Fifty companies, as well as with various heads of state, on how to adapt to a world where the dominant language is shifting from digital towards the language of life. He is a member of the Board of Directors of Cabot Corporation (NYSE: CBT), and he graduated from Harvard with a B.A. and M.B.A., both with honors.
Follow Juan Enriquez:
About Biotechonomy, Excel Venture Management, Viridos: Excel Venture Management builds companies that apply transformative life science technologies to solve problems in healthcare and beyond.
Rick Blume
Managing Director of Excel Venture Management
Rick Blume has been financing companies in healthcare for over three decades. His early investment banking career involved financing and banking relationships with hospitals, payers, physicians, and new biotech companies. The excitement he saw at Genentech, in its early years, led him to transition into venture capital in the mid 1980’s. Rick co-founded CB Health Ventures in 1998 where he assembled what is now the core of Excel including Enrico Petrillo, M.D., Steve Gullans, PhD, and Tricia Moriarty. Rick has served as a director or active investor in many companies including Lantos Technologies, Cytyc (acquired by Hologic – HOLX), AbT (now OSI – OSIP), Somatogen (acquired by Baxter – BAX), EdenTec (acquired by Nellcor), Exact Sciences (EXAS), IPC The Hospitalist Company (IPCM), GeneOhm (acquired by Becton Dickinson – BDX), Zonare, TransMedics, US Servis (acquired by McKesson); and the former public health insurance company Washington National. In addition to Excel, Rick has been active in initiating and teaching courses in venture capital and entrepreneurship at both Boston College Carroll School of Management and Simmons College School of Management, and serving on the Boards of the Chicago Biomedical Consortium and the National Regenerative Medicine Foundation .Rick did his undergraduate studies at University of the Pacific and Stanford. His MBA is from Stanford University.
Follow Rick Blume:
About CB Health Ventures, Excel Venture Management, GeneOhm Sciences, Zonare Medical Systems: Excel Venture Management builds companies that apply transformative life science technologies to solve problems in healthcare and beyond.
Stanley Lapidus
Board of Directors of Daktari Diagnostics
He is an experienced entrepreneur. He founded and served as CEO of three public companies, Cytyc, EXACT Sciences, and Helicos BioSciences. He currently serves as CEO of SynapDx Corp., which he founded in 2009 to develop novel diagnostics for autism. He teaches at the Biomedical Enterprise Program at MIT and is the inventor of 31 US patents.
Follow Stanley Lapidus:
About University of Colorado Anschutz Medical Campus: Daktari Diagnostics manufactures diagnostic medical products for clinicians and patients.
Ed Hammond
Director of Clinical Programs of Domain Surgical
Ed Hammond is the Director, Clinical Programs at OmniGuide.
Follow Ed Hammond:
About Domain Surgical, OmniGuide: Domain Surgical creates energy-based surgical products for precise soft tissue cutting and coagulation.
Michael Bartholomew
Co-Founder, Inside Director & Chief Commercial Officer of Promaxo
Mr. Michael Bartholomew is the EVP and Chief Commercial Officer at Promaxo. He has broad therapeutic experience across nearly twenty diseases covering large and small molecules, medical devices and diagnostics. Michael manages the go to market strategy, voice of customer, partner relationships and tactical implementation relating to corporate infrastructure. Prior to Promaxo, Michael was a Principal at Porzio Life Sciences, as well as Vice President of Sales & Marketing for Dohmen Life Science Service, where he developed and launched several commercial initiatives achieving sustained sales growth. Before Dohmen, he served in various sales and brand leadership positions for Pfizer, Pharmacia and Baxter. Michael proudly served in the US Air Force as a decorated combat aviator, where he achieved the rank of Captain. He received his Masters of Science in Administration from Central Michigan University and his Bachelor of Arts in Economics from Indiana University.
Follow Michael Bartholomew:
About Neuro42, Promaxo: Promaxo is commercializing customer-centric MRI systems and robotic guidance tools for live diagnosis and treatment in a physician’s office.
Milan Thakor
Director of Product of Blink Health
Milan Thakor is the director of product at Blink Health. He is a product and growth marketing leader with deep experience building early and growth stage companies.
Follow Milan Thakor:
About Blink Health: Blink Health is a web-based application that enables users to search for medical prescriptions online and pick them up from any pharmacy.
Joseph Authement
US Director Strategic Accounts-Robotics and Digital Solutions of Johnson & Johnson
Follow Joseph Authement:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Alice Lin Fabiano
Global Director of Social Innovation & Investment, Global Community Impact of Johnson & Johnson
Alice Lin Fabiano is a Global Director at Johnson & Johnson, Global Community Impact. In this capacity, she leads its social innovation strategy and investments in the discovery, engagement, and celebration of purpose driven entrepreneurs, with a focus in health technology and impact investing.
Follow Alice Lin Fabiano:
About Johnson & Johnson, Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Daniel Watts
Director, Global Process Owner, Global Contracting Solutions of Johnson & Johnson
Follow Daniel Watts:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Hari Kamaraju
Director and Head of Manufacturing Excellence, Advanced Therapies of Johnson & Johnson
Follow Hari Kamaraju:
About Janssen Belgium, Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Bret Evans
Sr Director IT of Johnson & Johnson
Currently Bret is the Sr. Director of IT Supply Chain for Johnson & Johnson Ethicon & CSS business.
Follow Bret Evans:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Rick Desmarais
Director Global JJOS Deployment Leader of Johnson & Johnson
Follow Rick Desmarais:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Joy Marini
Director of Corporate Contributions of Johnson & Johnson
Joy Marini became Director of Corporate Contributions in 2007, following 6 years with the Johnson & Johnson Pediatric Institute. Joy is responsible for Johnson & Johnson’s international programs on maternal and infant health, gender-based violence and gender inequality, and economic empowerment of women. She has been instrumental in developing sustainable partnership initiatives, most notably for her efforts on a Neonatal Resuscitation Program (NRP) in China — a 5-year collaboration between the Chinese Ministry of Health, the American Academy of Pediatrics (AAP), several Chinese health-professional organizations, and Johnson & Johnson, which reduced neonatal mortality by 54% in over 300 measured hospitals. Joy has contributed to the development of publications for parents and health professionals, including the Compendium of Postpartum Care with the Association of Women’s Health, Obstetrics and Neonatal Nursing, and Eating Behaviors of the Young Child with the AAP. Joy earned her MS Physician Assistant from the University of Medicine and Dentistry of New Jersey in 1997. She received an MBA from Rider University.
Follow Joy Marini:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Ravi Bhatia
Scientific Director of Johnson & Johnson
Follow Ravi Bhatia:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Reggie Fortson
Director of Product Lifecycle Management (PLM) of Johnson & Johnson
Follow Reggie Fortson:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Susan Can
Senior Director & Global Corporate Brand and Corporate Affairs of Johnson & Johnson
Follow Susan Can:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Susan Can
Senior Director & Global Corporate Brand and Corporate Affairs of Johnson & Johnson
Follow Susan Can:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Gregory Smith
IT Director, I&AM Engineering of Johnson & Johnson
Follow Gregory Smith:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Ping Gao
Center Director of Abbott
Follow Ping Gao:
About Abbott: Abbott is engaged in pharmaceuticals and manufacturing healthcare products.
Caroline Leab
Director, R&D of Abbott
Caroline Leab is a Director of Regulatory Affairs for Abbott, formerly St. Jude Medical. Caroline leads the EU MDR Implementation Program and Clinical Evaluation Process for the Abbott Cardiovascular and Neuromodulation organization. She has a background in Manufacturing and Quality Engineering with companies such as Boston Scientific and Nestle Healthcare Nutrition. Caroline led Quality organizations for AGA Medical and Monteris Medical before joining St. Jude Medical as a Director of R&D in 2014. Caroline serves on the Board of Directors for The Bakken Museum in Minneapolis and participates on various MDIC and AdvaMed committees.
Follow Caroline Leab:
About Abbott: Abbott is engaged in pharmaceuticals and manufacturing healthcare products.
Cliff Sirlin
Managing Director of LaunchCapital
Cliff Sirlin is a career entrepreneur who has founded and operates a portfolio of high growth businesses. Cliff is also an active Angel Investor. Cliff received his law degree from New York University School of Law. While at NYU, Cliff also studied at the Stern School of Business. He earned his BA in History from Colgate University. Cliff’s accomplishments have been profiled by CNBC; Inc. Magazine; Success Magazine; and Crain’s Business. Cliff also is a frequent lecturer at the NYU Stern School of Business.
Follow Cliff Sirlin:
About LaunchCapital, NYU Stern School of Business: LaunchCapital was founded in January 2008 with a mission to help entrepreneurs gain quick access to seed capital and mentorship.
Elon Boms
Founder, Board of Directors of LaunchCapital
Elon Boms co-founded LaunchCapital in January 2008 to help entrepreneurs gain quick access to seed capital and mentorship. With a passion for working with industry disruptors and teams that have a strong business development focus, Elon has been involved in over 75 deals across a wide range of industries and geographies. He holds an MBA from Yale School of Management and a BA in Economics from George Washington University. His prior work experience includes brand management, strategy consulting and finance. Elon lives in Connecticut with his wife, newborn daughter, and very shaggy dog.
Follow Elon Boms:
About LaunchCapital: LaunchCapital was founded in January 2008 with a mission to help entrepreneurs gain quick access to seed capital and mentorship.
Konstantine Drakonakis
Director, New Haven of LaunchCapital
Konstantine is an experienced early stage investor focused on proprietary technologies in the tri-state NY region. As an “Entrepreneurial Engineer”, Konstantine gravitates to technology companies within the software, med-tech and green-tech markets. He holds a Masters in Environmental Management from Yale University and a Civil and Environmental Engineering degree from the University of Vermont. He is a board certified Professional Engineer and is a member of the National Civil Engineering Honors Society. Konstantine lives in New Haven with his wife, 3 year old son and new baby girl. When he can, he finds a Zen moment in his garden.
Follow Konstantine Drakonakis:
About LaunchCapital: LaunchCapital was founded in January 2008 with a mission to help entrepreneurs gain quick access to seed capital and mentorship.
Konstantin Guericke
Member of the Board of Directors of StartX (Stanford-StartX Fund)
Konstantin Guericke is a Partner at Earlybird. He is based in Silicon Valley. Konstantin is Co – Founder of LinkedIn, where he has led marketing activities from launch to first six million members and profitability as Vice President of Marketing. Previously, he has been CEO of jaxtr (social communications start-up, over ten million registered users, purchased by SabSe Technologies). Konstantin has long-time entrepreneurial experience as founder of successful startups and he has helped established companies towards increased growth. Currently, he is Board member of several startups and Mentor of student entrepreneurs at Stanford University. Konstantin holds a B.S. and M.S. in Engineering from Stanford University.
Follow Konstantin Guericke:
About : StartX is an educational non-profit that helps Stanford’s top entrepreneurs.
Dan Ha
Co-Founder, Sr. Managing Director of StartX (Stanford-StartX Fund)
Follow Dan Ha:
About StartX (Stanford-StartX Fund): StartX is an educational non-profit that helps Stanford’s top entrepreneurs.
William C. Wortman
Director and Chairman of Exact Imaging
Mr. Wortman has been a director of Imagistx since April 2009. Mr. Wortman is presently a co-owner of Millennium Gaming. Inc. (MGI). MGI is the majority owner of Cannery Casino Resorts which owns and operates the Rampart Casino, Cannery Casino & Hotel and Eastside Cannery Casino & Hotel in Las Vegas and the Meadows Racetrack & Casino in Pennsylvania. Mr. Wortman began his career as an accountant with Laventhol & Horwath in 1974. In 1978 he joined Caesars Palace as financial controller and during the next six years, held various executive positions and though his efforts helped establish the Caesars brand as an industry leader. In 1983, Mr. Wortman purchased the Fallon Nugget and the Bonanza Inn and operated them until he sold them in 1996. In 1985, he purchased a substantial equity position in Nevada Palace in Las Vegas, a facility that was involved in a bankruptcy proceeding. Mr. Wortman, as managing partner assumed operating control restoring the facility to profitability. In 2006, Nevada Palace was sold to Cannery Casino Resorts. In addition to Imagistx, Mr. Wortman currently serves as a member of the UNLV Foundation Board of Trustees, board member of the UNLV Graduate School of Business, Board of Directors for Meadows Bank and the UNLV Leadership Campaign Committee. Mr. Wortman was the 1986 recipient of the Alumni of the Year Award for UNLV. Mr. Wortman received his Bachelor of Science in Accounting from UNLV.
Follow William C. Wortman:
About Cannery Casino Resorts LLC, Exact Imaging, Millennium Gaming. Inc: Exact Imaging is the developer of the ExactVu™ system, the first micro-ultrasound operating at 29 MHz that provides unmatched resolution.
Colton Pierson
Director Of Engineering of Curative
Follow Colton Pierson:
About Curative: Curative is a leader in on-demand public health programs and infrastructure. We’re building a healthier tomorrow, together.
Lixiao Wang
Founder, Chairman, and Board of Directors of Urotronic
Lixiao Wang is the Founder, Chairman, and Board of Directors of Urotronic, Inc.
Follow Lixiao Wang:
About Urotronic: A Minnesota based, medical device company, making an exciting innovation in urethral stricture treatment.
William Zollars
Member of the Board of Directors of Cerner
William Zollars was previously a ProLogis Member of the Board of Trustees from 2001 to 2010 and returned as a Member of the Prologis Board of Directors upon completion of the merger with AMB Property Corporation in 2011. In his current role as a Member of the Board of Directors, Bill serves on the Board Governance and Nomination Committee as well as the Compensation Committee. From 1999 to 2011, Bill was Chairman of the Board of Directors, President and Chief Executive Officer of YRC Worldwide, one of the largest and most recognizable global transportation service providers. Prior to that, Bill was President of Yellow Transportation, Inc., a position he accepted in 1996 as part of a major management transition for the company. From 1994 to 1996, Bill was senior Vice President of Ryder Integrated Logistics, a division of Ryder System, Inc., based in Miami, Florida. Previously, Bill spent 24 years in various executive positions at Eastman Kodak, including assignments in London, Toronto and Tokyo. In addition to Prologis, Bill currently serves on the boards of CIGNA Corporation, Cerner Corporation and the Carlson School of Management at the University of Minnesota. Bill is also Chairman of the Board of Directors at United Way of Greater Kansas City. Bill holds a Bachelor of Arts in Economics from the University of Minnesota and is a Member of Phi Beta Kappa.
Follow William Zollars:
About : Cerner is a supplier of healthcare information technology solutions, services, devices, and hardware.
Pete Smart
Sr. Director – Population Health – Data Analytics of Cerner
Peter is a Director in the population health analytics group of Cerner Corp., located in Kansas City, which is a leading provider of healthcare IT solutions including the Millennium EMR and Health Intent population health platform. He manages a multi-disciplinary consulting group, focusing on data warehousing implementations, analytics creation, organizational assessments, and general reporting and analytics needs. Peter has held various project manager roles across the United States and in Europe, with a bent towards providing quality and regulatory analytics based on clinical data. Peter works with his team and clients in creating actionable analytics based on clinical, operational, and financial data using Tableau. Peter has a master of science in information systems from the University of Kansas.
Follow Pete Smart:
About Cerner: Cerner is a supplier of healthcare information technology solutions, services, devices, and hardware.
Jim Poteet
Sr. Director, Revenue Cycle Development of Cerner
Follow Jim Poteet:
About Cerner: Cerner is a supplier of healthcare information technology solutions, services, devices, and hardware.
Jeff James
Director, Product Management of Cerner
Jeff is a Senior Software Architect in the Population Health Analytics group of Cerner Corporation in Kansas City. Cerner is a leading provider of Healthcare IT solutions including the Millennium EMR and Health Intent population health platform. Jeff specializes in healthcare data warehousing and is a strong proponent of agile development methods. He has strong domain knowledge and provides direction on security and privacy as well as technical issues. He uses Tableau to provide insight into clients’ operational deployment issues as well as clinical performance. He promotes Tableau through training to Cerner associates, presents at internal conferences, and moderating an internal discussion board. Jeff has a BSc in molecular genetics and molecular biology from the University of Toronto.
Follow Jeff James:
About Cerner: Cerner is a supplier of healthcare information technology solutions, services, devices, and hardware.
Anup Salgia
Medical Director, Premier Central of Cerner
Dr. Anup D. Salgia, DO, FACEP – Founder & Chairman LifeMedix, LLC., – Board Certified Emergency Physician, Lieutenant Commander, U.S Navy, Medical Corps (ret.); Asst. Prof. of Emergency Medicine, Northeast Ohio University of Medicine. Anup is the Founder and Chairman of LifeMedix, LLC. In an effort to bring updated, fresh technology to an old problem of fluid resuscitation in the field, Anup developed STATfusion™. STATfusion™ is an intravenous infusion device designed for use in combat and pre-hospital care. It is a platform device, as it has a multitude of uses that does not restrict its use to only IV resuscitation. Dr. Salgia is a board-certified emergency physician and practices at one of Ohio’s busiest emergency and trauma centers. While in the U.S. Navy, Anup served honorably with the US Marines. He was the Chief Medical Officer for the 24th Marine Expeditionary Unit, Special Operations. While deployed, he led close to one hundred men and women in an operational capacity. He was involved in the Kosovo Campaign and several NATO and U.S. operations and exercises. In addition, Dr. Salgia was the medical director of a branch medical clinic at Camp Lejune Marine Corps Base. Under his direction, the clinic was awarded several distinctions. He has been awarded several distinguished military awards and medals. Dr. Salgia trained at the National Naval Medical Center in Bethesda, Maryland, and the Cleveland Clinic-MetroHealth-Case Western Reserve University residency program in emergency medicine. His academic interests are in acute strokes and trauma resuscitation. At Aultman Hospital in Canton, Ohio, Anup led the emergency department in developing Stark County’s first acute stroke center. This stroke center now serves five surrounding counties. He is a spokesperson and Fellow of the American College of Emergency Physicians. He is an Assistant Professor of Emergency Medicine at the Northeast Ohio University of Medicine. In addition to practicing emergency medicine, Anup consults for the private equity and the legal sectors as an expert. In an effort to help victims of personal injury, Dr. Salgia co-founded Physicians Acute Care Clinics where doctors, physical therapists, nurses, and chiropractors work in concert to help patients overcome their injuries. Anup is a member of the Leadership Cleveland Class of 2012, bringing together the area’s business and civic leaders to elevate the Greater Cleveland area.
Follow Anup Salgia:
About Cerner: Cerner is a supplier of healthcare information technology solutions, services, devices, and hardware.
Greg Meyer
Director, Distinguished Engineer of Cerner
Greg (@Greg_Meyer93) is a director and distinguished engineer at Cerner Corporation and a 20 year Java veteran. He’s responsible for the architecture of the Cerner Direct solution and remains actively engaged in coding and mentoring new software engineers and upcoming architects. He has spent the last year migrating his solution to cloud native micro-services using Spring Boot, Spring Cloud, and Cloud Foundry and implementing a CI/CD strategy with Concourse. Outside of Cerner, Greg is responsible for the open source Direct Project Java reference implementation and is the primary source contributor. He also serves as a workgroup chair and contributing member of several national health care informatics, standards, and governance initiatives. Greg is also an accomplished musician and enjoys dabbling in music production.
Follow Greg Meyer:
About Cerner, Cerner: Cerner is a supplier of healthcare information technology solutions, services, devices, and hardware.
Samara Freeman
Director, IP & Regulatory Affairs of Evolve Biosystems
Samara was one of the co-founders of Evolve Biosystems. Samara has qualifications in both science and management and has worked in research management and biotech in the US and internationally. Samara has co-authored numerous scientific articles and is an invited and keynote speaker at milk and dairy conferences.
Follow Samara Freeman:
About Evolve Biosystems, Evolve Biosystems: Evolve Biosystems specializes in providing microbiome-based products designed to develop, restore, and maintain.
Dane Miller
Board of Directors of Biorez
Dane Miller received his B.S. Degree in Mechanical Materials Science Engineering from General Motors Institute in 1969. He then received a Masters Degree and Ph.D. in Materials Science-Biomedical Engineering from the University of Cincinnati in 1971 and 1974, respectively. Dr. Miller began his professional career at the Frigidaire Division, GMC in Dayton, Ohio from 1964 to 1969, working as a cooperative engineering student. From 1972 to 1975 he was employed at Zimmer U.S.A. in Warsaw, Indiana, in the position of Director of Biomedical Engineering. His responsibilities included engineering, prototype design and fabrication, as well as basic research support for all new product development programs. He was also responsible for coordinating and developing a custom and special product group, including marketing, sales, and manufacturing of custom products. From 1975 to 1978, Dr. Miller served as Director of Biomedical Engineering for Cutter Biomedical, a division of Cutter Laboratories, Inc., in San Diego, California. His responsibilities included organizing and staffing of a complete product development group, including formal budgeting and product planning functions. Finally, in 1978, Dr. Miller returned to Warsaw and, along with three other local individuals with orthopedic manufacturing experience formed Biomet, Inc. Their goal was to become the most responsive company in orthopedics while simultaneously providing patients with the highest quality and most clinically proven products in the marketplace. Since its inception in 1978 until March of 2006 Dr. Miller served as President and CEO of the company. With Dr. Miller at the helm, Biomet grew from $17,000 in sales its first year into one of the leading musculoskeletal companies in the world – with annual sales exceeding $2.7 billion. Since his retirement, Dr. Miller has participated with a group of private equity sponsors taking Biomet private in September of 2007 and serves on the Biomet Board of Directors.
Follow Dane Miller:
About : Biorez is a medicine company focused on the development of tendon and ligament healing.
Dave Ferrera
Director of Blockade Medical
Dave is Chief Technology Officer of Balt and a seasoned medical device executive with 20 years of experience working within the medical device and interventional neurovascular industry. Prior to Balt’s acquisition of Blockade Medical in 2016, he was a co-founding member of Blockade Medical, he also served as VP Product Development/Clinical Research & General Manager of MindFrame Inc.(acquired by Covidien in 2012), a developer, manufacturer and marketer of minimally invasive products for the treatment of acute ischemic stroke based in Irvine, CA. Prior to that he served as Director of Clinical Research/R&D for Microvention (acquired by Terumo in 2006), a developer, manufacturer and marketer of minimally invasive products for treatment of cerebral and vascular peripheral diseases based in Aliso Viejo, CA. His past roles have included Director of Technology Development of Micrus Endovascular (IPO in 2004 and acquired by J&J/Codman in 2010), Sr. R&D/Pilot Engineer of Boston Scientific in Watertown, MA, and R&D Process Engineer at IMPRA, Inc. in Tempe, AZ (acquired by C.R. Bard in 1996). Dave received a B.S. in Plastics Engineering from University of Lowell, in Lowell, Massachusetts. He holds several US and international patents for medical devices.
Follow Dave Ferrera:
About Balt, Blockade Medical, Sage Executive Group, Treadstone Holdings LLC: Founded in 2011, Blockade Medical is a privately held company dedicated the development of catheter based therapeutic devices for the
Bethany Salmon
Senior Director, Product Management of Bigfoot Biomedical
Follow Bethany Salmon:
About Bigfoot Biomedical: Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes.
Melissa Lee
Director of Community Relations of Bigfoot Biomedical
Follow Melissa Lee:
About Bigfoot Biomedical: Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes.
Melissa Lee
Director of Community Relations of Bigfoot Biomedical
Follow Melissa Lee:
About Bigfoot Biomedical: Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes.
Carl Chun
Member of Board of Directors of Paramit Corporation
Carl joined Paramit in 1992. He developed Paramit’s test infrastructure, including both test development and all levels of test and reliability into a core company strength. While at Paramit, Carl managed all engineering and quality functions. Prior to Paramit, Carl spent seven years at LTX-Trillium in Test Engineering and Development positions. He has a BSEE from Santa Clara University.
Follow Carl Chun:
About : Paramit designs and manufactures medical devices and life science instruments.
Merinda Do
Global Director of Human Resources of Paramit Corporation
Merinda joined Paramit in 2005 as the Director of Human Resources. She is responsible for all HR and employee development functions. Prior to joining Paramit, Merinda has held various HR Management positions at Zeta Defense Technology, CMAC, Solectron, and Fortinet. Merinda holds a BS in Economics Management, SPHR certified, and is a member of NCHRA, SHRM.
Follow Merinda Do:
About Paramit Corporation: Paramit designs and manufactures medical devices and life science instruments.
Mano Aryapour
Sr. Director of Program Management of Paramit Corporation
Mano Aryapour is the Senior Director, Program Management at Paramit Corp.
Follow Mano Aryapour:
About Paramit Corporation: Paramit designs and manufactures medical devices and life science instruments.
Jeffrey Thramann
Co-Founder & Director of Lanx
Jeff Thramann is a serial entrepreneur who was the founder and chairman of Lanx, a spinal implant company sold to Biomet, US Radiosurgery, an oncology services company sold to Alliance Healthcare Services (NASDAQ; AIQ), ProNerve, an intraoperative monitoring company sold to Waud Capital Partners and American Physicians, a hospitalist company sold to Towerbrook Partners. Prior to pursuing entrepreneurial endeavors, Thramann was the founder of Boulder Neurosurgical Associates in Boulder, CO. Thramann is the named inventor on over 50 U.S. and international issued and pending patents. He completed his neurosurgical residency and complex spinal reconstruction fellowship at the Barrow Neurological Institute in Phoenix, AZ. Medical school was completed at Cornell University Medical College in NYC and his undergraduate degree was earned at the United States Military Academy at West Point.
Follow Jeffrey Thramann:
About Lanx: Lanx employs its proprietary technology to develop spinal products for surgeons.
Daniel Martinson
Program Director – Digital, Robotics and Enabling Technologies of Stryker
Follow Daniel Martinson:
About Stryker: Stryker is a medical technology company that offers products and services in orthopaedics.
Ivan Lai
Senior Director, Global Supply Chain of Stryker
Follow Ivan Lai:
About Dexcom, Koderon, Stryker: Stryker is a medical technology company that offers products and services in orthopaedics.
Mark Mastandrea
Senior Director, Supply Chain of Stryker
Follow Mark Mastandrea:
About Stryker: Stryker is a medical technology company that offers products and services in orthopaedics.
Kevin Connors
Executive Director, Founder of Solace Therapeutics
Kevin Connors is an accomplished entrepreneur and venture investor. He has co-founded seven healthcare technology companies, and has had interim CEO roles in nine. These companies have focused on developing proprietary technology to address large un-met medical needs, such as emphysema, low back pain, cerebral aneurysm, and bladder dysfunction. Prior to founding Spray Venture Partners in 1996, Kevin was the founding CEO of Vesica Medical, a company focused on the surgical treatment of female urinary incontinence. Under this leadership, Vesica realized product sales within 18 months of formation and was acquired by Boston Scientific Corporation in 1995. Prior to Vesica, Kevin led medical device investment activity at DSV Partners in Newport Beach, California. Kevin is on the Board of Directors of the New England Venture Capital Association and MassMEDIC, the Massachusetts Medical Device Industry Council. He has served on the Board of Directors of Vesica Medical, Inc. (acquired by Boston Scientific), Masimo Corp., Pilot Cardiovascular (acquired by CR Bard), Circe Biomedical (acquired by ICN Pharmaceuticals), Gamera Bioscience (acquired by Tecan AG), and Endonetics (acquired by Medtronic). In addition to serving on our board, he also serves on the boards of, Facet Solutions, Leptos Biomedical, Solace Therapeutics, Highgate Orthopedics, and Cascade Ophthalmics. Kevin received a B.S. in Electrical Engineering from the University of Notre Dame, an M.S. in Electrical Engineering from the University of Dayton, and an M.B.A. from the Harvard Business School.
Follow Kevin Connors:
About AgenDx Biosciences, Solace Therapeutics, Spray Venture Partners: Solace Therapeutics develops and commercializes non-surgical office-based treatments for common bladder disorders.
Ben Moga
Director, Strategic Alliances of Varian
Follow Ben Moga:
About Varian: Varian Medical Systems is a manufacturer of medical devices and software for treating cancer and other medical conditions.
Nicholas J. Simon
Managing Director of The Blackstone Group Inc
Nicholas Simon has been a Managing Director of Clarus since the firm’s inception in 2005. Prior to Clarus, Nicholas Simon was a General Partner at MPM Capital, a healthcare venture capital firm. He has over 20 years of operating and investment experience in the biopharmaceutical industry including Genentech from 1989 to 2000 where he was Vice President of Business and Corporate Development. Nicholas Simon received a BS degree in microbiology from the University of Maryland and an MBA from Loyola University. Nicholas Simon is a Trustee at The J David Gladstone Institutes, a private not-for-profit research institute affiliated with the University of California, San Francisco.
Follow Nicholas J. Simon:
About Blackstone Life Sciences, ITM Solutions, The Blackstone Group Inc: Clarus Ventures is a Massachusetts-based venture capital firm focused on investments in the healthcare sector.
Michael Steinmetz
Managing Director of The Blackstone Group Inc
Michael Steinmetz, PhD, has been Managing Director of Clarus Ventures since the firm’s inception in 2005. Prior to Clarus, Dr. Steinmetz was a General Partner at MPM Capital, a healthcare venture capital firm. He has over 25 years of direct industry and investment experience within the healthcare sector. From 1986 to 1997, Dr. Steinmetz was an executive at Hoffmann-LaRoche where he held various positions including Vice President of Preclinical Research and Development, and Global Head of Biotechnology. Dr. Steinmetz obtained his PhD summa cum laude from the University of Munich and held positions at the California Institute of Technology and the Basel Institute for Immunology. Dr. Steinmetz represents Clarus Ventures on the Board of Directors of Heptares, Lycera, Oxford, TetraLogic, Variation, and Virdante. In addition, he is a member of the Board of Directors of Allozyne, Macrogenics, and TaiGen. Previous directorships include Acorda (NASDAQ:ACOR), Amphora, Arena (NASDAQ:ARNA), Atugen/SR Pharma (AIM:SPA), Biovitrum (merged into Swedish Orphan Biovitrum STO:SOBI), BioXell (SWX: BXLN), Caliper (NASDAQ:CALP), CGI Pharmaceuticals (acquired by Gilead), Coelecanth (acquired by Lexicon), ESBATech (acquired by Alcon), Epigenomics (FRK: ECX), GPC Biotech (merged into Agennix FRA:AGX), IDEA AG, Intracel Corp, ISB Accelerator, and VLST Corp.
Follow Michael Steinmetz:
About The Blackstone Group Inc: Clarus Ventures is a Massachusetts-based venture capital firm focused on investments in the healthcare sector.
Ron Zwanziger
Co-Founder, Chief Executive Officer, Chairman, and Director of LumiraDx
Ron Zwanziger, a strategic visionary and entrepreneur, is the CEO of LumiraDx, which he co-founded in 2014. He previously founded and led numerous successful diagnostic firms, including Alere, Inverness Medical Technology (which was acquired by Johnson & Johnson in 2001), and MediSense, the first company to introduce an electrochemical glucose sector. He currently serves on the Board of Directors of several private companies.
Follow Ron Zwanziger:
About LumiraDx: LumiraDx is a healthcare company that manufactures a diagnostic platform to support a menu of tests with lab comparable performance.
Geoffrey Parker
Board of Directors of ChemoCentryx
Geoffrey M. Parker has served as our Senior Vice President and Chief Financial Officer since September 2010, after serving in a consulting capacity since December 2009. From July 2009 to July 2010, Mr. Parker served in a consulting capacity as the Chief Business Officer of InteKrin Therapeutics, a privately held biopharmaceutical company in Los Altos, California. From 1997 to April 2009, Mr. Parker was a Vice President, then Managing Director and finally Partner at the global investment banking and securities firm Goldman Sachs Group, Inc., leading their West Coast Healthcare Investment Banking practice during this time. Mr. Parker also served in various capacities with Goldman Sachs Group, Inc. from 1990 to 1995 and 1986 to 1988. From 1995 to 1997, Mr. Parker was Vice President at Feibusch & Co., a venture capital firm in Larkspur, California. Mr. Parker is currently a member of the board of directors of Genoptix, Inc., a specialized laboratory service provider and ChemoCentryx, Inc., a clinical stage privately held biopharmaceutical company. Mr. Parker received an A.B. from Dartmouth College in Engineering Sciences and Economics and an M.B.A. from Stanford University.
Follow Geoffrey Parker:
About Tricida: ChemoCentryx develops orally administered small molecule therapeutics that target chemokine receptors and related chemo-attractants.
Rolf Classon
Member of the Board of Directors of Fresenius Medical Care
Rolf Classon has been a board member since August 2014. From October 2002 until his retirement in July 2004, Mr. Classon was Chairman of the Executive Committee of Bayer HealthCare AG, a subsidiary of Bayer AG. He served as President of Bayer Diagnostics from 1995 and 2002 and as Executive Vice President of Bayer Diagnostics from 1991 to 1995. Prior to 1991, Classon held various management positions with Pharmacia Corporation. From April 2005 to January 2015, Classon served as Chairman of the Board of Directors of Auxilium Pharmaceuticals, Inc. and as Vice Chairman from March 2005 to April 2005. Classon also currently serves as Chairman of the Board of Directors of Hill-Rom Corporation, where he also served as interim chief executive officer from May 2005 until March 2006. Classon currently serves as Chairman of the Board of Directors of Tecan Group Ltd. and as a member of the Board of Directors of Fresenius Medical Care. Classon previously served as a director of Millipore Corporation from December 2005 until July 2010, Prometheus Laboratories Inc. from September 2004 until 2010 and Enzon Pharmaceuticals Inc. from January 1997 until 2011. Classon received his Chemical Engineering Certificate from the Gothenburg School of Engineering and a Business Degree from the Gothenburg University.
Follow Rolf Classon:
About : Fresenius Medical Care is a healthcare company that provides dialysis treatment for those with chronic kidney diseases.
Darren Sherman
President, Chief Operating Officer, Director and Founder of Orchestra BioMed
Darren Sherman is a Managing Partner of Orchestra. He is also Chief Technical Officer of Accelerated Technologies, Inc. (ATI) as well as Chief Executive Officer of Caliber Therapeutics, Inc., an OMV II Fund Portfolio Company. He has over 17 years of management and entrepreneurial experience in the medical technology industry spanning interventional cardiology, cardiac electrophysiology, sudden cardiac death, stroke, and neurovascular therapies. He currently serves as a director of Caliber Therapeutics and Vivasure Medical. Prior to joining Orchestra, Mr. Sherman held various positions in executive management for Cordis Neurovascular (CNV), a Johnson & Johnson company, including Executive Director R&D and Director of Strategic Marketing for stroke products. He had worldwide responsibility for all neurovascular R&D and global strategic marketing responsibilities for the Stroke franchise, including budgets, portfolio of products and strategic planning. Mr. Sherman made significant contributions to the design and commercialization of a series of key products including the Enterprise Vascular Reconstruction Device and the Orbit Embolic Coil as well as directed the filing of over 100 patents. Prior to joining CNV, Mr. Sherman played an integral role in the formation and development of Revivant Corp (acquired by Zoll) while working with Thomas J. Fogarty, MD at Fogarty Engineering. He was Revivant’s first employee and managed the design, development, and testing of the AutoPulse device from concept through market introduction. In addition to the R&D related activities, Mr. Sherman supported the clinical research, marketing, and intellectual property efforts. The AutoPulse is a lightweight, portable tool replacing the need for manual chest compressions during cardio-pulmonary resuscitation (CPR) for patients suffering from sudden cardiac arrest. Prior to Revivant, Mr. Sherman held positions in research and development for Cardiac Pathways Corp., prior to its acquisition by Boston Scientific, and Baxter Healthcare. In each of these companies, he participated in the creation, development and launch of products. Mr. Sherman has authored 45 U.S. patents with an additional 58 published applications. He earned a BS degree in Bioengineering from the University of California, San Diego.
Follow Darren Sherman:
About Orchestra BioMed, Orchestra Medical Ventures: Orchestra BioMed is a biomedical innovation company that provides high-impact solutions for large unmet needs in procedure-based medicine.
Michael Van Der Woude
Operations Director of Emergo Group
Michael brings his experience in international business development to his role as COO. He has an extensive background in financial services and management, and holds a master’s degree from the University of Groningen.
Follow Michael Van Der Woude:
About Emergo Group, Emergo Group: Emergo Group is a medical device QA/RA consulting firm.
Li Weng
Director of AccuraGen Holdings
Li currently leads AccuraGen’s R&D. With her extensive knowledge and industry experience in genomic technology, she has spearheaded the development of a next generation sequencing (NGS)-based ctDNA assay suite which includes an amplicon-based NGS technology for SNV and fusion detection. Li is responsible for translating new technology developments into clinical actionables (LDT and potential IVD kit) for AccuraGen’s clinical labs in China as well as for GMP production. Li received her PhD in cancer biology from the University of Chicago and completed her postdoctoral studies at the Lawrence Berkeley National Laboratory where she worked on a sequencing-based assessment of human disease. She then moved to Affymetrix and later to Sequenta, where she managed the development and FDA-approval process of the company’s flagship product, a NGS-based technology for immuno profiling and MRD detection in patients with lymphoid cancer.
Follow Li Weng:
About AccuraGen Holdings: A cancer early detection company
Larry Papasan
Chairman of the Board of Directors of MEDOVEX
Larry Papasan is the retired President of Smith & Nephew Orthopedics. Larry joined Smith & Nephew in July, 1991 as President of the Ortho Division and retired December 31, 2002. During this 11-1/2 year period, the Division grew in sales from $300 million to $650 million while growing profitability at over 15% per year. Smith & Nephew Orthopedics is a company with manufacturing in Memphis and Germany. Larry was responsible for Research and Development, Manufacturing, Marketing, Sales and all Administrative functions of the Company during his 11-1/2 year tenure as President. Larry then worked for Smith & Nephew as a Director and Lobbyist until the end of 2005. Prior to joining Smith & Nephew, Larry was President of Memphis Light, Gas & Water Division from 1984 until his retirement in 1991. Larry was employed by MLG&W for 28 years. Larry has been a Member of the Board of Directors and Chairman of the Board of Directors of BioMimetic Therapeutics [NasdaqGM:BMTI] since August 2005. BioMimetic Therapeutics, Inc. is developing and commercializing bio-active recombinant protein-device combination products for the healing of musculoskeletal injuries and disease, including orthopedic, periodontal, spine and sports injury applications. Larry has also served as a Member of the Board of Directors at Reaves Utility Income Fund [NasdaqCM:UTG], a closed-end management investment company, since February 2003, SSR Engineering, Inc. and AxioMed Spine Corporation. Larry graduated from Mississippi State University in 1963 with a Bachelor of Science in Civil Engineering. Larry has completed numerous professional development courses, including the American Management Association Management course, Senior Management course and President’s course. Larry has been very active in the Memphis Community and was General Campaign Chairman of United Way in 1987 and Chairman of the Board from 1990-92, President of Kiwanis Club and President of Junior Achievement. Currently, he is involved with several organizations, some of which are BioMimetic Therapeutics, Inc., BioMedical Tissue Technologies, Ltd. and the Shelby Farms Park Conservancy. Larry is married and has two grown children and five grandchildren. He is an avid golfer.
Follow Larry Papasan:
About MB Venture Partners: MEDOVEX’s management team and board of directors are highly experienced healthcare professionals in all functional areas
Michael Hoey
Co-Founder, Chief Technology Officer & Board of Directors of NxThera
Michael Hoey is the Founder and CTO of NxThera.
Follow Michael Hoey:
About Francis Medical, NxThera: NxThera develops medical technologies to treat a variety of endourology conditions, including BPH.
Olivia Karpinski
Co-Founder and Director of Vivera Pharamceuticals
Ms. Karpinski is the Vice President of Sales and Marketing for Vivera Pharmaceuticals. Passionate about public health, Olivia has been in the healthcare industry for over 10 years. Her multifaceted expertise in product knowledge and business development helps her lead the sales team for Vivera while always seeking new, synergistic opportunities for the Company. Ms. Karpinski was formerly a Senior Business Analyst in the Medical Special Investigations Unit at Fortune 100 Company, Liberty Mutual. She is Lean Six Sigma certified and certified by the National Insurance Crime Bureau in special investigations and major medical fraud.
Follow Olivia Karpinski:
About Vivera Pharamceuticals: Vivera Pharmaceuticals is an innovative, science-driven pharmaceutical company located in Southern California.
Maria Berkman
Director of Broadview Ventures
Maria Berkman, MD, MBA, is a Director, and Head of the MedTech practice at Broadview Ventures. Maria shares responsibility for all aspects of Broadview’s investment activity, from identification and screening of new opportunities, through due diligence, negotiation of deal structure, and portfolio company board involvement. Prior to joining Broadview Ventures, Maria was a management consultant at Monitor Group (now Monitor Deloitte), where she specialized in life sciences with a focus on corporate, franchise, and asset-level commercialization strategy and competitive strategic planning for a broad range of BioPharma and MedTech clients. Prior to joining Monitor Group, Maria trained within the Partners HealthCare System at Newton Wellesley Hospital in General Surgery. Maria earned an MD from the UCLA School of Medicine, graduating Alpha Omega Alpha with a research focus in cardiothoracic and trauma surgery, and earned an MBA from the Anderson School of Management at UCLA. Maria serves on the boards of 480 Biomedical, Adient, BioKier, Cardialen, FineHeart, Vascular Graft Solutions, Vectorious, and Zumbro Discovery, and previously served on the boards of Apama (acquired by Boston Scientific) and Capricor (NASD:CAPR). In addition to her role at Broadview Ventures, Maria contributes time as a SBIR/STTR grant reviewer for the National Science Foundation and is a Strategic Advisory Board Member for the RAD BioMed Accelerator in Tel Aviv, Israel.
Follow Maria Berkman:
About Broadview Ventures, National Science Foundation: Broadview Ventures invests in businesses that focus on the development of technology solutions in cardiovascular and neurovascular diseases.
Christopher de Souza
Director of Broadview Ventures
Christopher de Souza, PhD, shares responsibility for the day-to-day operations of Broadview Ventures, including business development strategy, identification and screening of new investment opportunities, negotiation of partnering terms and deal structure, as well as portfolio company board involvement. He leverages 20 years of experience in biopharmaceutical R&D, business development and corporate strategy to help meet the Broadview Ventures mission. Christopher started his pharmaceutical career at Novartis where he was a senior scientist in the Metabolic and Cardiovascular Diseases group and then Director of Strategic Alliances with responsibilities for the therapeutic area strategy, business development and alliance management. After Novartis, Christopher was VP of Business Development at SkyePharma US Inc, a drug delivery company, where he was responsible for out-licensing SkyePharma’s clinical assets and drug delivery technologies. Christopher also founded a business development consulting practice with several clients including JSB-Partners, Diagnostics For All and Metaome.
Follow Christopher de Souza:
About Broadview Ventures: Broadview Ventures invests in businesses that focus on the development of technology solutions in cardiovascular and neurovascular diseases.
Christopher Colecchi
Managing Director of Broadview Ventures
Christopher Colecchi is the Managing Director of Broadview Ventures, the philanthropic venture investing arm of the Paris-based Leducq Family Trust. Broadview’s mission is to accelerate the development of cures for cardiovascular diseases through investments in promising early stage companies. Previously, Chris was the Vice President for Research Ventures and Licensing at Partners Healthcare–an integrated health system founded in 1994 by the Harvard-affiliated Brigham and Women’s Hospital and Massachusetts General Hospital. Chris led business development, technology transfer, and commercialization activities at Partners and managed efforts to establish strategic alliances with the life sciences industries. He also created the Partners Innovation Fund–an internal venture capital fund that makes investments in early stage science from Partners hospitals to create start-up companies to improve patient care. Earlier in his career, Chris was the Director of Clinical Trials and Industrial Relations for the Massachusetts General Hospital and Director of Clinical Monitoring for a clinical research organization (CRO) at which he oversaw the set-up and management of multi-center, industry-sponsored clinical trials at several hundred sites throughout the U.S. and Canada. Within these roles, Chris has worked directly with most of the major international pharmaceutical and biotechnology companies as well as many in the device arena.
Follow Christopher Colecchi:
About Broadview Ventures: Broadview Ventures invests in businesses that focus on the development of technology solutions in cardiovascular and neurovascular diseases.
Nichole Schiffer
Director of Operations of Broadview Ventures
Nichole manages day-to-day business operations, office administration, triaging of incoming investment opportunities, and meeting and event planning. Nichole also supports the investment team in its day-to-day operations.
Follow Nichole Schiffer:
About Broadview Ventures: Broadview Ventures invests in businesses that focus on the development of technology solutions in cardiovascular and neurovascular diseases.
Mark Mactas
Board of Director of Envision Healthcare
Mark Mactas was most recently deputy chairman, president and chief operating officer for Towers Watson until his retirement in 2011. He was formerly chairman and chief executive officer of Towers Perrin (before it merged with Watson Wyatt) from 2001 to 2009. With 14,000 associates around the world, Towers Watson offers professional services in benefits, talent management, rewards, and risk and capital management. Mark is currently vice chairman of the board of Save the Children, where he has been a trustee since 2006. Since 2011, he has served on the Board of Trustees and Executive Committee of Lehigh University. In 2013, he joined the Envision Healthcare board, which offers an array of healthcare-related services to consumers, hospitals, healthcare systems, health plans and local, state and national government entities. He also was president of the Conference of Consulting Actuaries and served on its board as well as that of the American Academy of Actuaries.
Follow Mark Mactas:
About : Envision Healthcare offers array of healthcare-related services to consumers, hospitals.
Carol J. Burt
Board of Director of Envision Healthcare
Follow Carol J. Burt:
About : Envision Healthcare offers array of healthcare-related services to consumers, hospitals.
Richard Schnall
Board of Director of Envision Healthcare
Rick Schnall is the Partner at Clayton Dubilier & Rice.
Follow Richard Schnall:
About CD&R LLP: Envision Healthcare offers array of healthcare-related services to consumers, hospitals.
James Shelton
Board of Director of Envision Healthcare
James D. Shelton was elected to Envision’s Board of Directors in May 2015. Mr. Shelton served as Chairman, Chief Executive Officer and President of Triad Hospitals, Inc., from 1999 until its sale in 2007. Prior to his leadership at Triad Hospitals, Mr. Shelton held numerous executive positions at Columbia/HCA Healthcare Corporation, serving as President of the Pacific Group from 1998 to 1999 and President of the Central Group from 1994 to 1998. Mr. Shelton serves as Chairman of the Board of Directors of Omnicare, Inc., and also was interim Chief Executive Officer of Omnicare from July through December 2010. He also is a member of the Board of Directors of Ventas, Inc. Mr. Shelton earned a bachelor’s degree from Louisiana State University and a Master of Science degree in public administration from University of Missouri-Columbia.
Follow James Shelton:
About : Envision Healthcare offers array of healthcare-related services to consumers, hospitals.
Liz Rockett
Managing Director of Kaiser Permanente Ventures
Follow Liz Rockett:
About Kaiser Permanente Ventures: Kaiser Permanente Ventures is a corporate venture capital firm investing in healthcare companies.
Amy Belt Raimundo
Managing Director of Kaiser Permanente Ventures
Amy Belt Raimundo joined Kaiser Permanente Ventures as managing director. Amy brings over 20 years of experience in healthcare investing, start-up and corporate operations and hospital system consulting. Immediately prior to joining Kaiser, Amy was the Chief Business Officer of digital health start-up Evidation Health founded by GE Ventures and Stanford Healthcare where she led all commercial and business development activities. Previously, Amy spent close to a decade in venture capital focused on healthcare technology as a Vice President at Covidien Ventures and Advanced Technology Ventures (ATV). She led investments in Medina Medial (acquired by Medtronic) and Nevro Corporation (NYSE: NVRO) among others. Earlier in her career, Amy held operating roles at Guidant Corporation (acquired by Abbott Vascular) including leading the international launch of the Xience drug eluting stent and managing product lines across the US, Europe and Asia. She began her career as a management consultant for APM/CSC Healthcare, optimizing operations and clinical guidelines for major hospital systems. Amy is a Kauffman Venture Fellow as well as founder and president of MedtechWomen. She holds a BA in Economics from Yale University and an MBA from the University of California at Berkeley.
Follow Amy Belt Raimundo:
About Covidien Ventures, Kaiser Permanente Ventures, MedTech Women: Kaiser Permanente Ventures is a corporate venture capital firm investing in healthcare companies.
Sam Brasch
Senior Managing Director; KP Venture of Kaiser Permanente Ventures
Follow Sam Brasch:
About Kaiser Permanente Ventures: Kaiser Permanente Ventures is a corporate venture capital firm investing in healthcare companies.
Chris Grant
Executive Managing Director of Kaiser Permanente Ventures
Chris Grant is a senior vice president at Kaiser Permanente and serves as a member of the senior executive management team. In addition to overseeing Corporate Development, Mergers and Acquisitions and Care Delivery Strategy, Grant is managing director of Kaiser Permanente’s venture capital group. Grant co-founded the investment program in 2000 and has overseen more than 50 investments in highly innovative medical technology companies. Kaiser Permanente’s successful venture investment function is designed to support the company’s health care mission while generating venture capital rates of return. Grant has served as a board director or advisor to over a dozen medical technology and service companies. Prior to the formation of the venture fund in 2000, Grant was responsible for creating, developing and managing a portfolio of new products and business lines for the organization. Before joining Kaiser Permanente in 1995, Grant held several positions on the Business Development and Financial Management Team of Rockwell International Corp. He served on Gov. Brown’s Job Creation Advisory Committee and currently serves on the boards of the East Bay Foundation for Health Education, the Pleasanton partnerships in Education Foundation and the Livermore Valley Performing Arts Council. He is a trustee of his local school district and serves as an advisor to the California Healthcare Foundation’s investment program and the Health and Science Department of Dominican University.
Follow Chris Grant:
About Kaiser Permanente Ventures: Kaiser Permanente Ventures is a corporate venture capital firm investing in healthcare companies.
Jennifer Spencer
Senior Director of Clinical Excellence of Texas Health Presbyterian Hospital Rockwall
Follow Jennifer Spencer:
About Texas Health Presbyterian Hospital Rockwall: Texas Health Presbyterian Hospital Rockwall is a hospital & health care firm offering acute care services.
Steve Archer
Sr. Director, Electrical Dev of NeuroPace
Follow Steve Archer:
About NeuroPace: NeuroPace develops and markets implantable devices for the treatment of neurological disorders.
Steve Archer
Sr. Director, Electrical Dev of NeuroPace
Follow Steve Archer:
About NeuroPace: NeuroPace develops and markets implantable devices for the treatment of neurological disorders.
Tamas Kovacs
Director, Product Development of Acera Surgical
Follow Tamas Kovacs:
About Acera Surgical: Develop a portfolio of fully synthetic surgical materials that act as nano-scale scaffold for tissue regeneration.
Svetlana Panasyuk
Board of Directors of Respiratory Motion
Dr. Svetlana Panasyuk brings strong software, image processing and algorithm skills critical for R & D efforts. Previously she was instrumental in developing the first clinical hyperspectral systems. Dr. Panasyuk’s training includes a Master’s Degree from Moscow Institute of Technology, a PhD in Physics from Massachusetts Institute of Technology, two Harvard fellowships and an MBA from Babson College. She has subsequently accrued extensive industry experience in all aspects of algorithm and software development, scientific experiment and data processing and the application of these skills toward the development of optical instrumentation and medical devices.
Follow Svetlana Panasyuk:
About : Respiratory Motion ExSpiron is FDA and CE Mark cleared and non-invasively measures minute ventilation, the fundamental unit of breathing.
Charles Koob
Member of the Board of Directors of MiMedx Group
Charles Koob is a Member of the Board of Directors at MiMedx. Charles joined the law firm of Simpson Thacher & Bartlett, LLP in 1970 and became a Partner in 1977. Charles retired from that firm on January 1, 2007 but remains of counsel. While at that firm, Charles was the Co-Head of the Litigation Department and served on the firm’s executive committee. Charles specializes in competition, trade regulation and antitrust issues. Throughout his 37-year tenure, he has represented clients before the Federal Trade Commission, the Antitrust Division of the Department of Justice and numerous state and foreign competition authorities. Charles’ resume includes the representation of Virgin Atlantic Airways, Archer Daniels Midland, and Kohlberg Kravis Roberts and Co. Charles received his B.A. degree from Rockhurst College in 1966 and his J.D. from Stanford Law School in 1969. In addition to his practice, Charles is a Trustee of the Natural Resources Defense Council, is President of the Yellowstone Park Foundation and is the Co-Chair of the Steering Committee for the current campaign for Stanford Law School. Charles is the brother of Dr. Thomas J. Koob, Chief Scientific Officer of MiMedx Group.
Follow Charles Koob:
About : MiMedx Group provides regenerative biologics utilizing human placental tissue allografts with patent-protected processes.
Terry Dewberry
Member of the Board of Directors of MiMedx Group
Terry Dewberry is a private investor with extensive experience at both the management and board levels in the healthcare industry. Terry most recently served as a Member of the Board of Directors with Respironics, Inc. and Matria Healthcare, Inc., where he served as a member of various committees including the Audit and Compensation committees. In 2008 both Respironics and Matria Healthcare were sold to larger companies. Terry currently serves on the board of DrTango, Inc., a private company in the multicultural communications and health management industry. Terry served as a Member of the Board of Directors, Vice Chairman of the Board of Directors, President and Chief Operating Officer, Executive Vice President and Chief Financial Officer of Healthdyne, Inc. from 1981 to 1996. Terry has extensive experience in corporate mergers and takeovers on both the buy and sell sides at sizes up to $5 billion.
Follow Terry Dewberry:
About : MiMedx Group provides regenerative biologics utilizing human placental tissue allografts with patent-protected processes.
Bruce Hack
Member of the Board of Directors of MiMedx Group
Bruce Hack is a Member of the Board of Directors at Overwolf since since April 2013. Bruce was Vice Chairman of the Board of Directors and Chief Corporate Officer of Activision Blizzard until 2009. Prior to that, Bruce was Chief Executive Officer of Vivendi Games, from 2004 to 2008, Vice Chairman of the Board of Directors of Universal Music Group, from 1998 to 2001 and Chief Financial Officer of Universal Studios, from 1995 to 1998. From 1982-1994, Bruce held several positions at The Seagram Company, including: Assistant to the Executive Vice President, Sales and Marketing for Seagram USA; Director, Strategic Planning, at The Seagram Company Ltd.; and Chief Financial Officer of Tropicana Products, Inc. Prior to this, Bruce was a trade negotiator for the U.S. Treasury. Bruce earned a B.A. degree at Cornell University and an MBA in Finance at the University of Chicago.
Follow Bruce Hack:
About : MiMedx Group provides regenerative biologics utilizing human placental tissue allografts with patent-protected processes.
Matthew Boretti
Director, Customer Experience of Teleflex
Follow Matthew Boretti:
About Teleflex: Teleflex is a diversified global company, distinguished by a significant presence in healthcare, with niche businesses.
Michael Rocca
Board Of Director of St. Jude Medical
Michael Rocca has been a member of our board of directors since March 2008. From 1994 to 2000, Michael Rocca served as Senior Vice President and Chief Financial Officer of Mallinckrodt Inc., a pharmaceutical and medical device manufacturer. Prior to 1994, Michael Rocca served in a variety of finance positions with Honeywell Inc., a diversified technology and manufacturing company, including Vice President, Treasurer and Vice President, Finance Europe. Michael Rocca also serves as a Director of St. Jude Medical Inc. Michael Rocca previously served as a Director of Lawson Software, Inc. from 2003-2011.
Follow Michael Rocca:
About : St. Jude Medical develops medical technology and services that focus on putting more control into the hands of those who treat cardiac,
Rick Devenuti
Director & Member, Audit Committee of St. Jude Medical
Rick Devenuti is President of the Information Intelligence Group (IIG), a division of EMC Corporation. With revenues of $21.7 billion in 2012 and 60,000 people worldwide, EMC is a global leader in enabling businesses and service providers to transform their operations and deliver IT as a service. Fundamental to this transformation is cloud computing. Through innovative products and services, EMC accelerates the journey to cloud computing, helping IT departments to store, manage, protect and analyze their most valuable asset—information—in a more agile, trusted and cost-efficient way. Devenuti was appointed to his current position in October 2010. In his role, Devenuti oversees all aspects of IIG’s business including worldwide sales and services, channel strategy, product development, marketing, strategic business and financial initiatives, IT, technical support and the Total Customer Experience program. He previously served as the division’s chief operating officer. He joined EMC following a successful 19-year career at Microsoft Corporation. Most recently, he served as Senior Vice President of Microsoft Services and IT responsible for strategy and operational performance of Microsoft Enterprise Services, Customer Service and Support, Software-as-a-Service business and IT. In that role, he significantly expanded the Enterprise Services business, introduced support offerings resulting in improved customer satisfaction and launched Microsoft Managed Services, the company’s first software-as-a-service offering for enterprise customers. Devenuti joined Microsoft in 1987 and focused his career on creating and managing operational excellence. As chief information officer, he established metrics to measure IT value at Microsoft and integrated business processes and business acumen into IT, resulting in efficiency gains for end users and cost savings for the company. Before becoming CIO, Devenuti was vice president of worldwide operations where he directed all activities related to Microsoft product information and release management, manufacturing, distribution, and transaction processing. He also held numerous operational positions at Microsoft including general manager of North American operations, general manager of U.S. sales operations, director of financial analysis, controller and cost accounting manager. Prior to Microsoft, he spent four years at Deloitte Touche as a Senior Accountant. Devenuti earned his Bachelor of Science Degree in Accounting from University of Washington. He currently serves on the Boards Of Directors for St. Jude Medical and Convergys Corporation.
Follow Rick Devenuti:
About Dell EMC: St. Jude Medical develops medical technology and services that focus on putting more control into the hands of those who treat cardiac,
Jamey Nielsen
Director of R&D of Zenflow
Jamey Nielsen is the ddirector of R&D at Zenflow, Inc.
Follow Jamey Nielsen:
About Zenflow: Zenflow is a medical company that gives new hope to men suffering from BPH symptoms.
Linda Heth
Associate Director IT of Zimmer Biomet
Follow Linda Heth:
About Zimmer Biomet: Zimmer Biomet designs, develops, manufactures, and markets orthopedic reconstructive and spinal products.
Ted Henderson
Managing Director of Schooner Capital
Ted has been a Managing Director at Schooner since 2004. Along with his colleagues, Ted invests across asset classes, domestically and abroad, with particular interest in domestic venture and growth stage companies, as well as alternative asset holdings in developing markets. Presently, Ted serves as a director at Orthocare Innovations, MediaSilo, Millstone Medical Outsourcing, Nanoscale Powders, Seventh Generation, SRS Medical, and Zixi. At Millstone Medical Outsourcing and Zixi, he serves as chairman. He is a past director of a number of Schooner investments, as well as several not-for-profit organizations. Prior to joining Schooner, Ted founded several enterprises in the for-profit education sector, served as a general manager at subsidiaries of The Washington Post Company, worked in venture capital at Fidelity Capital, and served global clients at Leo Burnett. Ted received an MBA from Harvard Business School and is a cum laude graduate of Dartmouth College, with a degree in Chinese language and culture.
Follow Ted Henderson:
About Schooner Capital: Schooner Capital is a Boston-based private investment firm engaged in venture capital, growth equity, and public securities.
Scott Yaphe
Managing Director of Schooner Capital
Scott is a Managing Director of Schooner Capital focused on investment opportunities in venture and growth-stage companies as well as alternative asset funds. Prior to Schooner, Scott spent 12 years as a General Partner at ABS Ventures, a multi-stage private investment firm. Scott has served on the board of directors of numerous companies including Adeptra (acquired by FICO), Synchronoss Technologies (NASDAQ:SNCR), Workbrain (TSX:WB) and Paratek (acquired by RIM). Before joining ABS Ventures, he was Director of Corporate Development at a telecommunications company as well as a management consultant with A.T. Kearney where he focused on corporate strategy in emerging market regions. Scott received his MBA from Harvard Business School and Bachelor of Commerce from McGill University.
Follow Scott Yaphe:
About Schooner Capital: Schooner Capital is a Boston-based private investment firm engaged in venture capital, growth equity, and public securities.
Peter Binas
Managing Director of Schooner Capital
Peter joined Schooner in 2008 as a Managing Director after almost ten years with management consultancy McKinsey & Company. While there, Peter specialized in corporate finance and strategy, advising leading players in the consumer packaged goods and retail industries in the US, Latin America and Western Europe. Core areas of focus included mergers and acquisitions, new market entry and growth strategies, competitive strategy, post-merger integration, and operational effectiveness. At Schooner, Peter serves as a director on the boards of RailComm, Colo Railroad Builders, Orthocare Innovations, and CustomMade. He also provides strategic and corporate finance support across the full portfolio . Peter holds a JD/MBA from Harvard Law and from Harvard Business School where he was a Baker scholar, and an AB with Honors from Harvard University where he graduated Phi Beta Kappa in Economics and Social Studies.
Follow Peter Binas:
About Schooner Capital: Schooner Capital is a Boston-based private investment firm engaged in venture capital, growth equity, and public securities.
Vicky Stennes
Director of Customer Experience and Retention of Steris
Vicky was Vice President, Inflight Experience at JetBlue Airways from 2003-2012 where she was responsible for in-flight service throughout the airline’s system, with the primary goal of maintaining the highest level of customer service standards while delivering the JetBlue experience at altitude. An industry veteran with over 35 years of aviation experience, she has a passion for serving crewmembers who serve customers. A frequent speaker on customer centricity, Vicky and her family reside in the New York area. She participates in a variety of community activities, and has also served on several aviation industry boards and organizations including her current role as President of the International Inflight Association.
Follow Vicky Stennes:
About Steris: STERIS is a provider of infection prevention and other procedural products and services.
Jeffrey Schell
Managing Director, CTO, Patent Attorney of Proov
Jeff’s mission is to transform innovative concepts into companies. In 2015, Jeff leveraged the valuable IP that he cultivated and developed to raise three million dollars in debt financing to acquire medical device company TranS1’s assets out of a failed merger. Within a few years of rebuilding TranS1 as CEO, ColoradoBiz Magazine named TranS1 one of the top 250 companies in Colorado by revenue. The Denver Post also named TranS1 Denver’s “Most Innovative Workplace” in 2016. Further, the Colorado Technology Association named TranS1 a nominee for “Company of the Year.” Under Jeff’s leadership, Orthopedics This Week awarded TranS1 with the 2017 Spine Technology Award. In 2018, Jeff had a successful exit from TranS1. In 2018, Jeff took a significant stake in Proov – evolving its underlying tech into multiple patent pending products and an emerging brand in women’s health – and he continues to play a leadership role. Soon thereafter, the company was featured in Forbes and won the “Best Family Tech at CES” award given by Parents Magazine. In 2019, the company won SXSW Startup of the Year. In 2020, the company raised several million dollars in VC and grant funding, gained distribution at leading retailers, won the coveted “Colorado Companies to Watch” recognition, and in 2021 grew to become named as one of the Denver Business Journal’s “25 largest biotechnology companies in Colorado.” Proov closed a $10MM Series A with the involvement of multiple prominent venture capital firms in 2021. In 2019, top tier law firm Hall Estill acquired the rights to the Rocky Mountain Patent brand. Jeff now leads the Ventures Growth practice for Hall Estill. In addition to building intellectual property strategies with the Rocky Mountain Patent team, Jeff now advises, operates and invests in multiple companies. Jeff is the former President of TiE Denver and remains heavily engaged with investment and startup advisory groups including Rockies Venture Club, BoomTown, TechStars and Prime Health. Jeff attended Northwestern University, graduating with degrees in Industrial Engineering & Management Sciences and Economics in 2004. He subsequently earned his JD and masters degrees in International Studies and Medical Informatics. Jeff separately studied economics at Harvard University, and in 2007, was a delegate at the Harvard China-India Development & Relations Symposium. ColoradoBiz Magazine named Jeff one of the 25 “Most Influential Young Professionals in Colorado” and he is a “40 under 40” honoree. He was also a finalist for the Denver Post’s “Colorado Innovator of the Year” and “Denver Trailblazer” awards. In 2017, Denver Mayor Michael Hancock invited Jeff to participate in Denver’s official trade delegation to South Africa and Kenya.
Follow Jeffrey Schell:
About MindMiner, Proov, Rocky Mountain Patent: Proov offers the most advanced system for women to evaluate their hormones at home, built upon patented, FDA cleared medical devices.
Floyd Loop
Member of the Board of Directors of OrthoSensor
Until his retirement in 2004, Floyd served the Cleveland Clinic Foundation for 35 years, holding leadership positions including Chief Executive Officer, Chairman of the Board of Governors (1989-2004) and Chairman of the Department of Thoracic and Cardiovascular Surgery. Floyd and his colleagues at the Cleveland Clinic were responsible for developing the use of arterial conduits in coronary artery surgery, innovations in valve repair and pioneering technical improvements for re-operations. Floyd has served as the President of the American Association for Thoracic Surgery, a Director of the American Board of Thoracic Surgery, and a member of the Medicare Payment Advisory Commission. He has received Honorary Doctor of Science degrees from Cleveland State University, St. Louis University and Purdue University. Floyd is an internationally recognized cardiovascular surgeon, a recipient of the American Heart Association Citation for International Service, and the American College of Cardiology Cummings Humanitarian Award. Floyd received his undergraduate degree from Purdue University and his M.D. from The George Washington University, Washington, D.C. His postgraduate training was at George Washington, the U.S. Air Force at Andrews Air Force Base and the Cleveland Clinic Foundation. Floyd currently serves on the public boards of Intuitive Surgical, Tenet Healthcare Corporation, Athersys, Inc., and other private boards.
Follow Floyd Loop:
About : OrthoSensor is a medical device company developing devices and data services for the orthopedic sector.
Kelly Mabry
Director of Research & Development of Tangible Science
Follow Kelly Mabry:
About Tangible Science, VIC Technology Venture Development: Tangible Science is a developer of contact lenses designed to reduce lens discomfort in dry eye diseases.
Renard Charity
Director of Fletcher Spaght, Inc.
Follow Renard Charity:
About Fletcher Spaght, Inc., Fletcher Spaght, Inc.: Fletcher Spaght, Inc. provides strategy and financial assistance to new ventures including start-ups.
Janice DiSanto
Director of Finance and Administration of Fletcher Spaght, Inc.
Janice DiSanto is the Director of Finance and Administration for Fletcher Spaght Ventures and its sister consulting firm, Fletcher Spaght, Inc. She has over 25 years of related experience, including financial analyses with the Federal Home Loan Bank of New York and Boston, and financial and administrative consulting positions with start-up businesses. Janice has a BS in Finance from Northeastern University.
Follow Janice DiSanto:
About Fletcher Spaght, Inc.: Fletcher Spaght, Inc. provides strategy and financial assistance to new ventures including start-ups.
